Strategic partnerships SWOG collaborates with multiple research networks and industry partners (ECOG-ACRIN collaboration, BostonGene, Agendia) under NCI funding, presenting opportunities to introduce complementary services, technology integrations, or joint grant-supported initiatives.

Clinical trial scale With over 20,000 members across 46 states and eight countries and ongoing large-scale trials, there is a strong readiness for tools and services that streamline protocol development, data management, statistical analysis, and quality assurance at scale.

Technology footprint SWOG utilizes a tech stack including iCIMS, Adobe, Microsoft products, Office 365, Zoom and web technologies, signaling openness to vendor solutions that enhance candidate recruiting, collaboration, data capture, and secure communications.

Leadership and governance Recent leadership updates and new committees such as the Advanced Practice Provider and Nurse Scientist Committee create entry points for professional education programs, trial operations support, and investigator training services aligned with NCTN grant cycles.

Funding and impact Public funding through NCI and a track record of influencing cancer care standards and drug approvals indicate willingness to invest in validated, impact-focused solutions—especially those demonstrating patient outcomes, regulatory compliance, and cost efficiency.